Aventis Wants Sens.' Letter Excluded In Arava Case

Law360, New York (October 7, 2008, 12:00 AM EDT) -- Sanofi-Aventis U.S. LLC and Aventis Pharmaceuticals Inc. are asking the judge overseeing a lawsuit accusing them of blocking generic competition for arthritis drug Arava not to allow a 2006 letter penned by former U.S. Sen. Trett Lott and current Sen. Debbie Stabenow to be introduced at trial.

Aventis filed a motion in limine Monday in the U.S. District Court for the Southern District of New York seeking to exclude the letter. Aventis also filed four other motions — two of which are under seal — on...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.